Mortality up in diabetes with low eGFR, no albuminuria

Mortality up in diabetes with low eGFR, no albuminuria

(HealthDay)—Among U.S. adults with diabetes, albumin-to-creatinine ratio (ACR) values are decreasing, but mortality rates are increasing among those with ACR <30 mg/g and low estimated glomerular filtration rates (eGFRs), according to a study published online Feb. 7 in Diabetes Care.

Holly Kramer, M.D., M.P.H., from Loyola University Chicago, and colleagues used data from the National Health and Nutrition Examination Surveys 1988 to 2006 to examine mortality trends in adults with diabetes. Via linkage with the National Death Index, mortality trends were examined by chronic kidney disease phenotype (eGFR and urine ACR level).

The researchers found that from 1988 to 2006, there was an increase in adults with an eGFR <60 mL/min/1.73 m² and an ACR <30 mg/g, from ~0.9 million (6.6 percent of the total population with diabetes during 1988 to 1994) to 2.4 million (10.1 percent of the total population with diabetes during 2007 to 2010). There was a general downward trend in for adults with diabetes and an ACR ≥30 mg/g, but an increase was seen among those with an eGFR <60 mL/min/1.73 m² and an ACR <30mg/g, from 35 to 51 deaths per 1,000 persons years during 1988-1994 to 2003-2006.

"ACR values are decreasing in U.S. adults with , but optimal management strategies are needed to reduce mortality in those with a low eGFR and an ACR <30 mg/g," the authors write.

More information: Abstract/Full Text (subscription or payment may be required)

Journal information: Diabetes Care

Copyright © 2018 HealthDay. All rights reserved.

Citation: Mortality up in diabetes with low eGFR, no albuminuria (2018, February 12) retrieved 29 March 2024 from https://medicalxpress.com/news/2018-02-mortality-diabetes-egfr-albuminuria.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

ACE inhibitor, statin no benefit for T1DM, high albumin excretion

11 shares

Feedback to editors